Pneumonia News and Research

Latest Pneumonia News and Research

Computerised diagnostic model outperforms clinical judgement for diagnosing children with febrile illness

A computerised diagnostic model outperforms clinical judgement for the diagnosis of fever in young children, and may improve early treatment, finds a study published on bmj.com today.

21 Apr 2010

Forest Laboratories' fourth-quarter net sales up 11.0% to $995.6M

Forest Laboratories, Inc., an international pharmaceutical manufacturer and marketer, announced that diluted earnings per share equaled $0.07 in the fourth quarter of fiscal 2010.

21 Apr 2010

New in vitro study results of Hydrofiber dressing to be presented at SAWC/WHS 2010

ConvaTec, a world-leading developer and marketer of innovative medical technologies for community and hospital care, today announced new in vitro study results in which a Hydrofiber dressing containing ionic silver was observed to conform more closely to a porcine tissue surface in a shallow wound model than did certain silver-containing foam dressings following hydration.

19 Apr 2010

Lack of health insurance to delay emergency treatment during heart attack: Study

Lack of health insurance and financial worries about the cost of care contributed to as much as a six-hour delay in seeking emergency care for a heart attack, according to a first-of-its kind study published April 14 in the Journal of the American Medical Association.

17 Apr 2010

Research roundup: Revamping NCI Clinical Trials, reducing malpractice suits, health disparities persist

A National Cancer Clinical Trials System For The 21st Century: Reinvigorating The NCI Cooperative Group Program - The "system for conducting cancer clinical trials in the United States is approaching a state of crisis," according to this report on inefficiencies and funding issues faced by the NCI's Clinical Trials Cooperative Group Program - which comprises 10 groups, more than 3,100 institutions, 14,000 investigators and more than 25,000 patients in clinical trials each year.

17 Apr 2010

Results of study comparing REMICADE to azathioprine for Crohn's disease published

Findings published today in The New England Journal of Medicine from a first-of-its-kind comparator trial evaluating the anti-tumor necrosis factor (TNF)-alpha biologic treatment REMICADE (infliximab) in the treatment of moderately to severely active Crohn's disease in patients who were naive to immunomodulator and biologic therapy, showed that a significantly greater proportion of patients receiving REMICADE achieved steroid-free remission and mucosal healing compared with patients receiving azathioprine.

16 Apr 2010

Federal report details health care quality across states; Online system ranks quality at Illinois hospitals

A Maryland Web site explores how the state ranked in a federal report about health care quality while other news operations look at an online site offered in Illinois that assesses hospitals there.

16 Apr 2010

Seasonal flu tends to move in traveling waves: Researchers

An analysis of hospitalization records for adults age 65 and over found that seasonal flu tends to move in traveling waves, peaking earliest in western states such as Nevada, Utah, and California and working its way east. New England states such as Rhode Island, Maine, and New Hampshire tend to have the latest peak in seasonal flu, according to public health researchers at Tufts University in Boston.

16 Apr 2010

Long-term monitoring and education needed to protect lungs of young patients

St. Jude Children's Research Hospital investigators have identified childhood cancer survivors who are at increased risk for deteriorating lung health, in part due to the lifesaving bone marrow transplants they underwent years earlier.

16 Apr 2010

Genocea Biosciences, NMRC sign CRADA to develop vaccine against malaria

Genocea Biosciences, a leading vaccine discovery and development company, today announced that it has entered into a Cooperative Research and Development Agreement with the Naval Medical Research Center. NMRC will collaborate with Genocea to identify antigens that will be used in the development of a vaccine candidate against Plasmodium falciparum for the prevention of malaria.

16 Apr 2010

Opinions: Health and living conditions; H1N1, one year later; global water shortages

Former U.S. Senate Majority Leader Bill Frist (R-Tenn.) and Habitat for Humanity CEO Jonathan Reckford write in an Atlanta Journal-Constitution opinion piece about the need to "address the constant crisis families face daily in deplorable living conditions."

15 Apr 2010

Kenta Biotech presents positive Phase IIa results of panobacumab

Kenta Biotech has presented positive Phase IIa results of its lead drug candidate, panobacumab (KBPA101), with all patients completing the treatment for hospital-acquired pneumonia and ventilator-acquired pneumonia caused by P. aeruginosa achieving an effective clearance of pneumonia as well as a 100% survival rate.

15 Apr 2010

A renewed effort to reduce global toll of maternal and child deaths

Widespread global use of known and proven maternal and childcare techniques, practices, and therapies could save the lives of millions of women, newborns and children each year, according to a new analysis prepared for a mid-April meeting of world leaders and technical experts on maternal and child health.

15 Apr 2010

Financial concerns can delay heart attack treatment

A study published Tuesday in the Journal of the American Medical Association reports that financial concerns can lead people having heart attacks to delay treatment.

15 Apr 2010

Hospital acquired infections on the increase

Despite being reported over a decade ago, little has been done in America to reduce hospital born infections as per a Health and Human Services department quality report for 2009 to Congress. Hospital acquired infections seem to be on the increase according to the report when compared with statistics available for 2007. The situation is being seen as critical by many health care experts.

14 Apr 2010

Alkermes submits VIVITROL sNDA for opioid dependence

Alkermes, Inc. today announced that it has submitted a supplemental New Drug Application (sNDA) for VIVITROL® (naltrexone for extended-release injectable suspension) to the U.S. Food and Drug Administration (FDA) for approval as a treatment for opioid dependence. The company requested a priority review for its sNDA and if granted by the FDA, it would mean a six month review timeline.

13 Apr 2010

Antibiotic-resistant pneumococci increase rate of bacterial infections in children

In the decade since the introduction of pneumococcal vaccination, significant shifts have occurred in the bacterial strains causing serious pneumococcal infections in children, according to a pair of studies in the April issue of The Pediatric Infectious Disease Journal (www.PIDJ.com). The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health, a leading provider of information and business intelligence for students, professionals, and institutions in medicine, nursing, allied health, and pharmacy.

13 Apr 2010

Cempra to make poster presentations on CEM-101 and CEM-102 at ECCMID 2010

Cempra Pharmaceuticals today announced poster presentations on its novel antibiotic CEM-101, a next-generation macrolide, and CEM-102, the company's proprietary front-loading oral dosing regimen of sodium fusidate, at the 20th European Congress of Clinical Microbiology and Infectious Disease, April 10 to 13, 2010, in Vienna Austria.

12 Apr 2010

WHO Director-General turns attention to conditions in slums to mark World Health Day

WHO Director-General Margaret Chan said addressing living conditions in the world's slums is important to improving urban health - the focus of World Health Day on Wednesday, Agence France-Presse reports.

9 Apr 2010

Cempra Pharmaceuticals announces schedule of poster presentations at ECCMID 2010

Cempra Pharmaceuticals today announced its schedule of poster presentations at the 20th European Congress of Clinical Microbiology and Infectious Disease (ECCMID) in Vienna, Austria, on April 10-13, 2010.

8 Apr 2010

Pneumonia News and Research

Latest Pneumonia News and Research

Computerised diagnostic model outperforms clinical judgement for diagnosing children with febrile illness

Forest Laboratories' fourth-quarter net sales up 11.0% to $995.6M

New in vitro study results of Hydrofiber dressing to be presented at SAWC/WHS 2010

Lack of health insurance to delay emergency treatment during heart attack: Study

Research roundup: Revamping NCI Clinical Trials, reducing malpractice suits, health disparities persist

Results of study comparing REMICADE to azathioprine for Crohn's disease published

Federal report details health care quality across states; Online system ranks quality at Illinois hospitals

Seasonal flu tends to move in traveling waves: Researchers

Long-term monitoring and education needed to protect lungs of young patients

Genocea Biosciences, NMRC sign CRADA to develop vaccine against malaria

Opinions: Health and living conditions; H1N1, one year later; global water shortages

Kenta Biotech presents positive Phase IIa results of panobacumab

A renewed effort to reduce global toll of maternal and child deaths

Financial concerns can delay heart attack treatment

Hospital acquired infections on the increase

Alkermes submits VIVITROL sNDA for opioid dependence

Antibiotic-resistant pneumococci increase rate of bacterial infections in children

Cempra to make poster presentations on CEM-101 and CEM-102 at ECCMID 2010

WHO Director-General turns attention to conditions in slums to mark World Health Day

Cempra Pharmaceuticals announces schedule of poster presentations at ECCMID 2010

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Pneumonia News and Research

Latest Pneumonia News and Research

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in